Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17989707rdf:typepubmed:Citationlld:pubmed
pubmed-article:17989707lifeskim:mentionsumls-concept:C0024109lld:lifeskim
pubmed-article:17989707lifeskim:mentionsumls-concept:C0026336lld:lifeskim
pubmed-article:17989707lifeskim:mentionsumls-concept:C0021853lld:lifeskim
pubmed-article:17989707lifeskim:mentionsumls-concept:C0023884lld:lifeskim
pubmed-article:17989707lifeskim:mentionsumls-concept:C0039198lld:lifeskim
pubmed-article:17989707lifeskim:mentionsumls-concept:C0856825lld:lifeskim
pubmed-article:17989707lifeskim:mentionsumls-concept:C1527144lld:lifeskim
pubmed-article:17989707lifeskim:mentionsumls-concept:C0591833lld:lifeskim
pubmed-article:17989707pubmed:issue3lld:pubmed
pubmed-article:17989707pubmed:dateCreated2008-1-22lld:pubmed
pubmed-article:17989707pubmed:abstractTextAdoptive transfer of CD4+CD25+ regulatory T cells has been shown to have therapeutic effects in experimental graft-vs-host disease (GVHD) models. Chemokines play an important role in the recruitment of alloreactive donor T cells into target organs during GVHD. In this study, we investigated the effectiveness of targeted delivery of CD4+CD25+ regulatory T cells via a transfected chemokine receptor on reduction of organ damage during acute GVHD. High levels of expression of Th1-associated chemokines (CXCL9, CXCL10 and CXCL11) and their receptor CXCR3 were observed in the liver, lung and intestine of GVHD-induced recipient mice. Recipient mice that had undergone transfer of CD4+CD25+Foxp3+ CXCR3-transfected T cells (CXCR3-Treg cells) showed significant amelioration of GVHD changes in the liver, lung and intestine in comparison with recipient mice that had received CD4+CD25+Foxp3+ T cells (Treg cells) or naturally occurring CD4+CD25+ regulatory T cells. This was due to more pronounced migration of CXCR3-Treg cells and their localization for a longer time in Th1-associated chemokine-expressing organs, resulting in stronger suppressive activity. We succeeded in preparing chemokine receptor-expressing Treg cells and demonstrated their ability to ameliorate disease progression upon accumulation in target organs. This method may provide a new therapeutic approach for organ damage in acute GVHD.lld:pubmed
pubmed-article:17989707pubmed:languageenglld:pubmed
pubmed-article:17989707pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17989707pubmed:citationSubsetIMlld:pubmed
pubmed-article:17989707pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17989707pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17989707pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17989707pubmed:statusMEDLINElld:pubmed
pubmed-article:17989707pubmed:monthFeblld:pubmed
pubmed-article:17989707pubmed:issn1476-5462lld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:LeuFFlld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:MOENH MHMlld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:KohnoMMlld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:MiyazakiTTlld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:HasegawaHHlld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:InoueAAlld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:YasukawaMMlld:pubmed
pubmed-article:17989707pubmed:authorpubmed-author:YoshiiCClld:pubmed
pubmed-article:17989707pubmed:issnTypeElectroniclld:pubmed
pubmed-article:17989707pubmed:volume15lld:pubmed
pubmed-article:17989707pubmed:ownerNLMlld:pubmed
pubmed-article:17989707pubmed:authorsCompleteYlld:pubmed
pubmed-article:17989707pubmed:pagination171-82lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:meshHeadingpubmed-meshheading:17989707...lld:pubmed
pubmed-article:17989707pubmed:year2008lld:pubmed
pubmed-article:17989707pubmed:articleTitleTherapeutic effect of CXCR3-expressing regulatory T cells on liver, lung and intestinal damages in a murine acute GVHD model.lld:pubmed
pubmed-article:17989707pubmed:affiliationDepartment of Bioregulatory Medicine, Ehime University Graduate School of Medicine, Ehime, Japan. hitoshih@m.ehime-u.ac.jplld:pubmed
pubmed-article:17989707pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:17989707pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17989707lld:pubmed